Menu

Olivia Egge

Survivor/Advocate
Olivia Egge was diagnosed with Osteosarcoma in 2017. Since then, she inspires the search for new OS treatments by sharing valuable patient insights. Olivia is currently a 4th-year student at the University of Virginia.
See full team
Olivia Egge
Survivor Badge RingSurvivor Badge Inner
Background

Olivia Egge was diagnosed with Osteosarcoma (OS) in February 2017, following a severe treatment protocol that has not advanced in forty years. Ms. Egge has given us the inspiration to search for new cures for OS, while continually giving us the patient perspective. She is an active 4th Year at the University of Virginia.

Our Pipeline

The Future of Cancer Treatment

OS Therapies is not just addressing Osteosarcoma. With the other uses of our HER2 target cancer immunotherapy and the addition of our OST-tADC tunable Antibody Drug Conjugate silicone linker platform, we are paving the way for the next-generation of cancer treatments.
Female chemist working on osteosarcoma treatments | OS TherapiesLab technician working on cancer treatments | OS TherapiesFemale chemist working on cancer treatments